Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene expression profiling in cluster headache: a pilot microarray study.

Christina Sjöstrand1, Kristina Duvefelt, Anna Steinberg

  • 1Clinical Neuroscience--Neurology, Karolinska University Hospital, Huddinge, 14186 Stockholm, Sweden.

Headache
|November 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interaction between smoking and <i>HLA-A*02:01</i> in multiple sclerosis progression.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Trajectories of processing speed in multiple sclerosis across disease-modifying therapies.

Journal of neurology·2026
Same author

Genetic variability within molecular core clock genes in cluster headache.

Cephalalgia : an international journal of headache·2026
Same author

A target trial emulation of the CONFIRM study with an extension to subgroups: an example for relapsing-remitting multiple sclerosis.

European journal of epidemiology·2026
Same author

A HIF1A variant impacts long-term disability and smoldering inflammation in multiple sclerosis.

Acta neuropathologica·2026
Same author

Neurofilament Light Chain Concentration in the Prediction of Treatment Response in Multiple Sclerosis.

European journal of neurology·2026

Cluster headache (CH) involves inflammation, with S100 proteins and HLA-DQ genes upregulated during attacks. This pilot study identifies potential biomarkers for CH, paving the way for further research into this debilitating neurological condition.

Area of Science:

  • Neuroscience
  • Genomics
  • Immunology

Background:

  • Cluster headache (CH) is a severe neurovascular disorder characterized by intense pain and autonomic symptoms.
  • Pathophysiology is linked to hypothalamic and trigeminovascular systems, with potential roles for inflammation and immune responses.
  • Understanding genetic changes during CH phases may reveal disease mechanisms.

Purpose of the Study:

  • To identify differentially expressed genes in peripheral blood during various clinical phases of cluster headache.
  • To investigate potential pathophysiological changes reflected in peripheral venous blood.
  • To explore genetic markers associated with CH activity and remission.

Main Methods:

  • Microarray analysis of global gene expression using the Affymetrix Human Genome U133 2.0 Plus GeneChip Set.

Related Experiment Videos

  • Blood samples collected from 3 episodic CH patients during attacks, between attacks, and in remission.
  • Quantitative RT-PCR validation for S100P gene expression in 6 patients and 14 controls.

    • Main Results:

    • Upregulation of S100 calcium-binding proteins (S100A8, S100A12, S100P) during the active phase of CH compared to remission.
    • Increased expression of Annexin A3 and ICAM3 during active CH.
    • Upregulation of HLA-DQA1 and HLA-DQB1 genes in CH patients compared to controls, confirmed for S100P by RT-PCR.

    Conclusions:

    • S100A8 and S100A12 are potential markers for non-infectious inflammation in CH.
    • Upregulation of pro-inflammatory genes, including HLA-DQ, during active CH phases suggests an inflammatory component.
    • This pilot study provides a foundation for further research into CH pathogenesis and biomarker discovery.